Advertisement
Research ArticleCellular and Molecular

Is GPR17 a P2Y/Leukotriene Receptor? Examination of Uracil Nucleotides, Nucleotide Sugars, and Cysteinyl Leukotrienes as Agonists of GPR17

Ai-Dong Qi, T. Kendall Harden and Robert A. Nicholas
Journal of Pharmacology and Experimental Therapeutics October 2013, 347 (1) 38-46; DOI: https://doi.org/10.1124/jpet.113.207647
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleCellular and Molecular

GPR17 Is Not Activated by UDP, UDP-Sugars, or Leukotrienes

Ai-Dong Qi, T. Kendall Harden and Robert A. Nicholas
Journal of Pharmacology and Experimental Therapeutics October 1, 2013, 347 (1) 38-46; DOI: https://doi.org/10.1124/jpet.113.207647
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement